| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |